Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Teva and Kowa form generics JV for Japan; Teva later takes over

Executive Summary

Israeli generics company Teva Pharmaceutical and Kowa Co. (Japanese pharma and life sciences, as well as non-medical consumer goods, textiles, and chemicals) have signed a definitive agreement to form Teva-Kowa Pharma Co. Ltd., a 50/50 joint venture being established to promote generic drugs in Japan.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • Joint Venture
    • R&D and Marketing (Licensing)

Related Companies